The rate of people dying from bowel cancer in the UK has plummeted by more than 30 per cent in the last 20 years.
Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.
Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease.
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment.
Cancer Research UK and Macmillan Cancer Support welcome the Government’s response to the National Data Guardian Review.